FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncohaematology, and can be used to monitor the effectiveness of the anti-tumour treatment of patients with multiple myeloma. For this purpose the concentration of free light chains of immunoglobulins is determined before and 24 hours after finishing the treatment course. In case of a 60% reduction of the concentration, the performed treatment is considered to be effective, in case the reduction of the concentration is 60% and lower - ineffective.
EFFECT: application of the claimed method makes it possible to obtain data about the treatment effectiveness in short terms, which increases the probability of remission achievement due to individual adequate selection of a scheme for anti-tumour treatment.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING RENAL DAMAGE IN PATIENTS WITH A PRIMARILY IDENTIFIED SECRETING MULTIPLE MYELOMA | 2017 |
|
RU2652082C1 |
| METHOD OF CHEMOTHERAPY EFFICIENCY PREDICTION IN PATIENTS WITH MALIGNANT GLIOMA | 2007 |
|
RU2341794C1 |
| METHOD OF TREATING T-CELL LYMPHOMAS AND KAPOSIS'S SARCOMA | 2009 |
|
RU2401671C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD OF ONCOLOGICAL PATIENTS TREATMENT | 2007 |
|
RU2341306C1 |
| METHOD OF TEACHING MALIGNANT BRAIN GLIOMA | 2009 |
|
RU2402360C1 |
| METHOD FOR TREATING EXACERBATIONS IN CASE OF MULTIPLE SCLEROSIS | 2003 |
|
RU2257915C2 |
| METHOD OF SKIN SARCOIDOSIS TREATMENT | 2010 |
|
RU2442588C2 |
| METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
| METHOD OF TREATMENT OF MALIGNANT BRAIN TUMORS | 2015 |
|
RU2578472C1 |
